Evidence map›Paper›PMID 30642275›Full record

ArticleBMC medical genetics2019

A novel mutation in SEPN1 causing rigid spine muscular dystrophy 1: a Case report.

Fateme Ziyaee, Eslam Shorafa, Hassan Dastsooz, Parham Habibzadeh, Hamid Nemati, Amir Saeed, Mohammad Silawi, Mohammad Ali Farazi Fard, Mohammad Ali Faghihi, Seyed Alireza Dastgheib

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Fateme ZiyaeeDepartment of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.
Eslam ShorafaDepartment of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.
Hassan DastsoozItalian Institute for Genomic Medicine (IIGM), University of Turin, Turin, Italy.
Parham HabibzadehPersian BayanGene Research and Training Center, Dr. Faghihi's Medical Genetic Center, Shiraz, Iran.ORCID 0000-0002-2086-0425
Hamid NematiShiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Amir SaeedDepartment of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad SilawiPersian BayanGene Research and Training Center, Dr. Faghihi's Medical Genetic Center, Shiraz, Iran.
Mohammad Ali Farazi FardPersian BayanGene Research and Training Center, Dr. Faghihi's Medical Genetic Center, Shiraz, Iran.
Mohammad Ali FaghihiPersian BayanGene Research and Training Center, Dr. Faghihi's Medical Genetic Center, Shiraz, Iran.
Seyed Alireza DastgheibPersian BayanGene Research and Training Center, Dr. Faghihi's Medical Genetic Center, Shiraz, Iran. Dastgheib@sums.ac.ir.ORCID 0000-0003-4781-301X
Shiraz University of Medical Sciences · IRFaghihi Hospital · IRItalian institute for Genomic Medicine · ITUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMuscular dystrophies are a clinically and genetically heterogeneous group of disorders characterized by variable degrees of progressive muscle degeneration and weakness. There is a wide variability in the age of onset, symptoms and rate of progression in subtypes of these disorders. Herein, we present the results of our study conducted to identify the pathogenic genetic variation involved in our patient affected by rigid spine muscular dystrophy. CASE PRESENTATION: A 14-year-old boy, product of a first-cousin marriage, was enrolled in our study with failure to thrive, fatigue, muscular dystrophy, generalized muscular atrophy, kyphoscoliosis, and flexion contracture of the knees and elbows. Whole-exome sequencing (WES) was carried out on the DNA of the patient to investigate all coding regions and uncovered a novel, homozygous missense mutation in SEPN1 gene (c. 1379 C > T, p.Ser460Phe). This mutation has not been reported before in different public variant databases and also our database (BayanGene), so it is classified as a variation of unknown significance (VUS). Subsequently, it was confirmed that the novel variation was homozygous in our patient and heterozygous in his parents. Different bioinformatics tools showed the damaging effects of the variant on protein. Multiple sequence alignment using BLASTP on ExPASy and WebLogo, revealed the conservation of the mutated residue.

conclusionWe reported a novel homozygous mutation in SEPN1 gene that expands our understanding of rigid spine muscular dystrophy. Although bioinformatics analyses of results were in favor of the pathogenicity of the mutation, functional studies are needed to establish the pathogenicity of the variant.

Indexed as

Genetic Predisposition to DiseaseMutationAdolescentAmino Acid SequenceDNA Mutational AnalysisGenetic TestingGenetic VariationHigh-Throughput Nucleotide SequencingHomozygoteHumansIranMaleMallory BodiesMuscle ProteinsMuscular AtrophyMuscular DystrophiesMuscle ProteinsSELENON protein, humanSelenoproteinsMuscular dystrophiesNovel mutationRigid spine muscular dystrophySelenoproteinsSEPN1

Identifiers

PMID30642275
PMCPMC6332642
OpenAlexW2912473609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.